Filing Details

Accession Number:
0001179110-13-013874
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-09-05 17:32:37
Reporting Period:
2013-09-04
Filing Date:
2013-09-05
Accepted Time:
2013-09-05 17:32:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203343 Dave Wentz 3838 West Parkway Blvd
Salt Lake City UT 84120
C.e.o. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-09-04 11,700 $26.06 485,655 No 4 M Direct
Common Stock Disposition 2013-09-04 11,700 $77.92 473,955 No 4 S Direct
Common Stock Acquisiton 2013-09-05 2,004 $26.06 475,959 No 4 M Direct
Common Stock Disposition 2013-09-05 2,004 $78.00 473,955 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2013-09-04 17,581 $0.00 17,581 $26.06
Common Stock Stock-Settled Stock Appreciation Rights Disposition 2013-09-05 3,010 $0.00 3,010 $26.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,101 2009-07-21 2014-01-21 No 4 M Direct
11,091 2009-07-21 2014-01-21 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
  2. Average Price. Price range was $77.90 to $78.05.